TY - JOUR
T1 - Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain
AU - Bogie, Jeroen F.J.
AU - Grajchen, Elien
AU - Wouters, Elien
AU - Corrales, Aida Garcia
AU - Dierckx, Tess
AU - Vanherle, Sam
AU - Mailleux, Jo
AU - Gervois, Pascal
AU - Wolfs, Esther
AU - Dehairs, Jonas
AU - Van Broeckhoven, Jana
AU - Bowman, Andrew P.
AU - Lambrichts, Ivo
AU - Gustafsson, Jan-Ake
AU - Remaley, Alan T.
AU - Mulder, Monique
AU - Swinnen, Johannes V.
AU - Haidar, Mansour
AU - Ellis, Shane R.
AU - Ntambi, James M.
AU - Zelcer, Noam
AU - Hendriks, Jerome J.A.
PY - 2020/5/4
Y1 - 2020/5/4
N2 - Failure of remyelination underlies the progressive nature of demyelinating diseases such as multiple sclerosis. Macrophages and microglia are crucially involved in the formation and repair of demyelinated lesions. Here we show that myelin uptake temporarily skewed these phagocytes toward a disease-resolving phenotype, while sustained intracellular accumulation of myelin induced a lesion-promoting phenotype. This phenotypic shift was controlled by stearoyl-CoA desaturase-1 (SCD1), an enzyme responsible for the desaturation of saturated fatty acids. Monounsaturated fatty acids generated by SCD1 reduced the surface abundance of the cholesterol efflux transporter ABCA1, which in turn promoted lipid accumulation and induced an inflammatory phagocyte phenotype. Pharmacological inhibition or phagocyte-specific deficiency of Scd1 accelerated remyelination ex vivo and in vivo. These findings identify SCD1 as a novel therapeutic target to promote remyelination.
AB - Failure of remyelination underlies the progressive nature of demyelinating diseases such as multiple sclerosis. Macrophages and microglia are crucially involved in the formation and repair of demyelinated lesions. Here we show that myelin uptake temporarily skewed these phagocytes toward a disease-resolving phenotype, while sustained intracellular accumulation of myelin induced a lesion-promoting phenotype. This phenotypic shift was controlled by stearoyl-CoA desaturase-1 (SCD1), an enzyme responsible for the desaturation of saturated fatty acids. Monounsaturated fatty acids generated by SCD1 reduced the surface abundance of the cholesterol efflux transporter ABCA1, which in turn promoted lipid accumulation and induced an inflammatory phagocyte phenotype. Pharmacological inhibition or phagocyte-specific deficiency of Scd1 accelerated remyelination ex vivo and in vivo. These findings identify SCD1 as a novel therapeutic target to promote remyelination.
UR - http://www.scopus.com/inward/record.url?scp=85080029943&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080029943&partnerID=8YFLogxK
U2 - 10.1084/jem.20191660
DO - 10.1084/jem.20191660
M3 - Article
C2 - 32097464
VL - 217
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
SN - 0022-1007
IS - 5
ER -